SAETTA, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.807
AS - Asia 6.931
EU - Europa 4.722
AF - Africa 2.021
SA - Sud America 1.582
OC - Oceania 190
Continente sconosciuto - Info sul continente non disponibili 111
Totale 35.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.792
SG - Singapore 2.409
CN - Cina 1.212
BR - Brasile 998
HK - Hong Kong 900
SE - Svezia 547
FI - Finlandia 541
VN - Vietnam 482
DE - Germania 455
IT - Italia 417
UA - Ucraina 288
FR - Francia 256
RU - Federazione Russa 207
GB - Regno Unito 192
PL - Polonia 188
IN - India 132
NL - Olanda 129
MX - Messico 106
TR - Turchia 104
AR - Argentina 95
CI - Costa d'Avorio 94
IE - Irlanda 92
AT - Austria 74
AO - Angola 73
EC - Ecuador 73
ID - Indonesia 73
JP - Giappone 73
ZA - Sudafrica 72
BJ - Benin 69
ES - Italia 69
KR - Corea 69
EG - Egitto 68
IQ - Iraq 68
TN - Tunisia 65
AE - Emirati Arabi Uniti 64
CA - Canada 64
NP - Nepal 63
AL - Albania 61
BY - Bielorussia 61
DZ - Algeria 61
PH - Filippine 61
BE - Belgio 60
EE - Estonia 59
CW - ???statistics.table.value.countryCode.CW??? 58
MA - Marocco 58
VE - Venezuela 58
BG - Bulgaria 57
CZ - Repubblica Ceca 57
GN - Guinea 57
IL - Israele 57
MZ - Mozambico 57
UZ - Uzbekistan 57
JM - Giamaica 56
JO - Giordania 56
PE - Perù 56
BA - Bosnia-Erzegovina 55
CD - Congo 55
GF - Guiana Francese 55
LB - Libano 55
PA - Panama 55
BF - Burkina Faso 54
HR - Croazia 54
SO - Somalia 54
TW - Taiwan 54
AU - Australia 53
AZ - Azerbaigian 53
BB - Barbados 53
GE - Georgia 53
LU - Lussemburgo 53
PS - Palestinian Territory 53
RO - Romania 53
SN - Senegal 53
TT - Trinidad e Tobago 53
CH - Svizzera 52
KZ - Kazakistan 52
NI - Nicaragua 52
TJ - Tagikistan 52
CL - Cile 51
DK - Danimarca 51
MY - Malesia 51
ZM - Zambia 51
BO - Bolivia 50
CO - Colombia 50
GH - Ghana 50
GM - Gambi 50
PK - Pakistan 50
RS - Serbia 50
GT - Guatemala 49
MD - Moldavia 49
ME - Montenegro 49
MU - Mauritius 49
HU - Ungheria 48
LC - Santa Lucia 48
UY - Uruguay 48
DO - Repubblica Dominicana 47
GR - Grecia 47
KE - Kenya 47
LY - Libia 47
NE - Niger 47
NO - Norvegia 47
Totale 33.022
Salva come PNG Salva come JPEG
Città #
Fairfield 2.538
Woodbridge 2.124
Ashburn 1.531
Singapore 1.494
Chandler 1.400
Houston 1.374
Ann Arbor 1.344
Jacksonville 1.010
Wilmington 897
Seattle 883
Hong Kong 865
Cambridge 807
Princeton 440
Boardman 412
Beijing 345
Dong Ket 278
Santa Clara 272
San Diego 251
Des Moines 240
Helsinki 209
Los Angeles 176
Nanjing 171
Roxbury 168
Munich 152
Medford 149
Bytom 119
Padova 94
Abidjan 87
Chicago 87
Ho Chi Minh City 85
Dublin 83
São Paulo 82
New York 79
Cotonou 63
Luanda 62
Turku 57
Conakry 55
Hefei 55
Dakar 53
Buffalo 52
Panama City 52
Lusaka 51
Managua 51
Baku 50
Bridgetown 50
Hebei 50
London 50
Tashkent 50
Amman 49
Dushanbe 49
Shenyang 48
Vienna 48
Accra 47
Nanchang 47
Willemstad 47
Castries 46
Cayenne 45
Kinshasa 45
Tallinn 44
Bishkek 43
Jinan 43
Maputo 43
Minsk 43
Niamey 43
Ulan Bator 43
Kigali 42
Praia 42
Changsha 41
Falls Church 41
Bamako 40
Montevideo 40
Nairobi 40
Nouakchott 40
Podgorica 40
Riga 40
Dallas 39
Kampala 39
Libreville 39
Tbilisi 39
Phnom Penh 38
Yerevan 38
Zagreb 38
Harare 37
Havana 37
Kingston 37
Salt Lake City 37
Vientiane 37
Antananarivo 36
Djibouti 36
Kingstown 35
Lima 35
Ogden 35
Reykjavik 35
San José 35
Tirana 35
Brooklyn 34
Dar es Salaam 34
Hanoi 34
Johannesburg 34
Nassau 34
Totale 23.133
Salva come PNG Salva come JPEG
Nome #
Reduced apoptosis of CD8+ T-lymphocytes in the airways of smokers with mild/moderate COPD. 270
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 234
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment 233
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease 220
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 216
Immune inflammation and disease progression in idiopathic pulmonary fibrosis 209
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 209
Airway inflammation in childhood asthma 204
Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing 201
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 196
High viral frequency in children with gastroesophageal reflux-related chronic respiratory disorders. 194
Clinical and pathologic factors predicting future Asthma in wheezing children: A longitudinal study 190
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. 187
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology 187
AIRWAY MUCOSAL INFLAMMATION IN OCCUPATIONAL ASTHMA INDUCED BY TOLUENE DIISOCYANATE 185
COPD-related adenocarcinoma presents low aggressiveness morphological and molecular features compared to smoker tumours. 185
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 181
Alpha-1 antitrypsin deficiency: Beyond the protease/antiprotease paradigm 180
Airway inflammation in severe chronic obstructive pulmonary disease 179
Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence 175
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) 174
Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations. 173
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 172
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 168
Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma 167
Small airway morphology and lung function in the transition from normality to chronic airway obstruction 166
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma. 166
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study 165
Quality standards for the management of bronchiectasis in Italy: A national audit 163
An asthmatic patient with progressive lung dysfunction: a case of misdiagnosis. 160
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 159
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department 159
IN-VITRO EXPOSURE TO NITROGEN-DIOXIDE (NO2) DOES NOT ALTER BRONCHIAL SMOOTH-MUSCLE RESPONSIVENESS IN OVALBUMIN-SENSITIZED GUINEA-PIGS 158
MECHANISMS AND PATHOLOGY OF OCCUPATIONAL ASTHMA 158
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 158
Alpha-1 antitrypsin deficiency today: New insights in the immunological pathways 158
Blood eosinophils relate to atopy and not to tissue eosinophils in wheezing children 158
Airway inflammation in chronic obstructive pulmonary disease 157
AIRWAY WALL REMODELING AFTER CESSATION OF EXPOSURE TO ISOCYANATES IN SENSITIZED ASTHMATIC SUBJECTS 156
Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease 156
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline 156
Effect of inhalation of thermal water on airway inflammation in chronic obstructive pulmonary disease 154
EFFECT OF CESSATION OF EXPOSURE TO TOLUENE DIISOCYANATE (TDI) ON BRONCHIAL-MUCOSA OF SUBJECTS WITH TDI-INDUCED ASTHMA 153
Ceramide Expression and Cell Homeostasis in Chronic Obstructive Pulmonary Disease. 153
α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency 152
Pathophysiology of the small airways 151
CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome. 151
UP-REGULATION OF ADHESION MOLECULES IN THE BRONCHIAL MUCOSA OF SUBJECTS WITH CHRONIC OBSTRUCTIVE BRONCHITIS 150
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 150
Risk Factors for Development and Severity of COVID-19 in COPD Patients 150
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial 149
AIRWAY EOSINOPHILIA IN CHRONIC-BRONCHITIS DURING EXACERBATIONS 149
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis 149
LATE ASTHMATIC REACTIONS, AIRWAY INFLAMMATION AND CHRONIC ASTHMA IN TOLUENE-DIISOCYANATE-SENSITIZED SUBJECTS 148
CD8 T-CELL CLONES PRODUCING INTERLEUKIN-5 AND INTERFERON-GAMMA IN BRONCHIAL-MUCOSA OF PATIENTS WITH ASTHMA INDUCED BY TOLUENE DIISOCYANATE 148
TOLUENE DIISOCYANATE-STIMULATED RELEASE OF ARACHIDONIC-ACID METABOLITES IN THE ORGAN BATH FROM GUINEA-PIG AIRWAYS 147
Air pollution exposure impairs airway epithelium IFN-β expression in pre-school children 147
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 146
AIRWAY INFLAMMATION DURING LATE ASTHMATIC REACTIONS INDUCED BY TOLUENE DIISOCYANATE 145
Increased activation of p38 MAPK in COPD 145
EFFECT OF SMOKING CESSATION ON AIRWAY INFLAMMATION IN CHRONIC-BRONCHITIS 145
Evasion of copd in smokers. at what price? 145
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 144
Bronchiolitis obliterans organizing pneumonia (BOOP) in a child with mild-to-moderate asthma: evidence of mast cell and eosinophil recruitment in lung specimens 144
Expiratory pattern of newborn mammals. 143
ACTIVATED LYMPHOCYTES-T AND EOSINOPHILS IN THE BRONCHIAL-MUCOSA IN ISOCYANATE-INDUCED ASTHMA 142
IN-VITRO EXPOSURE OF GUINEA-PIG MAIN BRONCHI TO 2-CENTER-DOT-5 PPM OF NITROGEN-DIOXIDE DOES NOT ALTER AIRWAY SMOOTH-MUSCLE RESPONSE 142
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 142
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 142
Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis. 142
Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19 142
EFFECT OF BUMETANIDE ON TOLUENE DIISOCYANATE INDUCED CONTRACTIONS IN GUINEA-PIG AIRWAYS 141
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 141
Mechanical aspects of chest wall distortion. 141
MAST-CELLS IN THE AIRWAY MUCOSA AND RAPID DEVELOPMENT OF OCCUPATIONAL ASTHMA INDUCED BY TOLUENE DIISOCYANATE 141
Epithelial damage and angiogenesis in the airways of children with asthma. 140
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis 139
Up-regulated membrane and nuclear leukotriene B4 receptors in COPD 138
Mast Cell Infiltration Discriminates Between Histopathological Phenotypes of Chronic Obstructive Pulmonary Disease. 137
Air Pollution Relates to Airway Pathology in Wheezing Children 137
EFFECTS OF INHALED BECLOMETHASONE ON AIRWAY RESPONSIVENESS IN OCCUPATIONAL ASTHMA - PLACEBO-CONTROLLED STUDY OF SUBJECTS SENSITIZED TO TOLUENE DIISOCYANATE 136
Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab 136
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 135
Predominant emphysema phenotype in chronic obstructive pulmonary disease patients 134
THE EFFECTS OF TOLUENE DIISOCYANATE AND OF CAPSAICIN ON HUMAN BRONCHIAL SMOOTH-MUSCLE IN-VITRO 134
The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma 134
Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate 134
Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI) 134
Pneumothorax and/or pneumomediastinum worsens the prognosis of covid-19 patients with severe acute respiratory failure: A multicenter retrospective case-control study in the north-east of italy 134
To reg or not to reg: that is the question in COPD 133
Severity of airflow limitation is associated with severity of airway inflammation in smokers 133
[Relation between non-specific bronchial hyperreactivity, smoking, atopy and respiratory function conditions in non-asthmatic subjects]. 133
Fatal asthma in a subject sensitized to toluene diisocyanate. 133
Neutrophilic infiltration within the airway smooth muscle in patients with COPD 132
Exome sequencing reveals immune genes as susceptibility modifiers in a1-antitrypsin deficiency 132
Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction. 131
ACTIVATED LYMPHOCYTES-T AND MACROPHAGES IN BRONCHIAL-MUCOSA OF SUBJECTS WITH CHRONIC-BRONCHITIS 131
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 131
Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children 130
Decreased expression of TGF-beta type II receptor in bronchial glands of smokers with COPD 129
Totale 15.766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.085
article - articoli 99.736
book - libri 470
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.388
Totale 216.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.196 0 0 0 0 72 229 150 233 440 326 347 399
2021/20223.589 144 407 436 362 132 177 186 429 154 101 355 706
2022/20232.865 597 240 48 318 455 475 3 191 324 24 148 42
2023/20241.307 52 221 127 105 91 147 67 80 53 36 176 152
2024/20255.524 25 302 300 223 703 196 276 422 548 253 991 1.285
2025/202610.242 842 2.098 3.242 3.879 181 0 0 0 0 0 0 0
Totale 35.663